|
1
|
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.
|
Clin Infect Dis
|
2011
|
16.88
|
|
2
|
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.
|
Am J Respir Crit Care Med
|
2003
|
14.40
|
|
3
|
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.
|
Antivir Ther
|
2008
|
2.93
|
|
4
|
Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.
|
Clin Infect Dis
|
2008
|
2.69
|
|
5
|
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
|
Am J Med
|
2008
|
2.55
|
|
6
|
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
|
Am J Respir Crit Care Med
|
2004
|
2.40
|
|
7
|
Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.
|
J Infect Dis
|
2007
|
2.28
|
|
8
|
Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess.
|
Arch Intern Med
|
2011
|
2.17
|
|
9
|
Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings.
|
Sex Transm Dis
|
2006
|
2.07
|
|
10
|
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.
|
AIDS
|
2008
|
2.02
|
|
11
|
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?
|
Am J Respir Crit Care Med
|
2004
|
1.96
|
|
12
|
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.
|
AIDS
|
2009
|
1.95
|
|
13
|
Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.
|
Clin Infect Dis
|
2010
|
1.59
|
|
14
|
Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting.
|
Am J Med
|
2013
|
1.44
|
|
15
|
Widespread emergence of methicillin resistance in community-acquired Staphylococcus aureus infections in Denver.
|
South Med J
|
2005
|
1.44
|
|
16
|
Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis.
|
Pharmacotherapy
|
2002
|
1.31
|
|
17
|
Skin-test screening and tuberculosis transmission among the homeless.
|
Emerg Infect Dis
|
2002
|
1.28
|
|
18
|
Grade 4 events are as important as AIDS events in the era of HAART.
|
J Acquir Immune Defic Syndr
|
2003
|
1.21
|
|
19
|
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.
|
AIDS
|
2010
|
1.20
|
|
20
|
How much directly observed therapy is enough?
|
Am J Respir Crit Care Med
|
2004
|
1.10
|
|
21
|
Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
|
Infect Control Hosp Epidemiol
|
2009
|
1.07
|
|
22
|
Selective drug taking during combination antiretroviral therapy in an unselected clinic population.
|
J Acquir Immune Defic Syndr
|
2005
|
1.07
|
|
23
|
Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.
|
Infect Control Hosp Epidemiol
|
2014
|
1.04
|
|
24
|
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.
|
Proc Natl Acad Sci U S A
|
2013
|
1.00
|
|
25
|
Tuberculosis in patients with HIV infection.
|
Infect Dis Clin North Am
|
2002
|
1.00
|
|
26
|
HIV transmission risk behavior and its relation to antiretroviral treatment adherence.
|
Sex Transm Dis
|
2003
|
0.99
|
|
27
|
Durability of adherence to antiretroviral therapy on initial and subsequent regimens.
|
AIDS Patient Care STDS
|
2006
|
0.96
|
|
28
|
The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics.
|
PLoS One
|
2013
|
0.96
|
|
29
|
Education level, primary language, and comprehension of the informed consent process.
|
J Empir Res Hum Res Ethics
|
2007
|
0.95
|
|
30
|
The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care.
|
Appl Health Econ Health Policy
|
2008
|
0.92
|
|
31
|
The association between symptoms and microbiologically defined response to tuberculosis treatment.
|
Ann Am Thorac Soc
|
2013
|
0.92
|
|
32
|
The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment.
|
Am J Respir Crit Care Med
|
2003
|
0.91
|
|
33
|
Initial linkage and subsequent retention in HIV care for a newly diagnosed HIV-infected cohort in Denver, Colorado.
|
J Int Assoc Provid AIDS Care
|
2013
|
0.90
|
|
34
|
Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.
|
AIDS Patient Care STDS
|
2014
|
0.80
|
|
35
|
Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.
|
Acad Emerg Med
|
2012
|
0.79
|
|
36
|
Clinical characteristics and antibiotic utilization in pediatric patients hospitalized with acute bacterial skin and skin structure infection.
|
Pediatr Infect Dis J
|
2014
|
0.79
|
|
37
|
Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess.
|
J Hosp Med
|
2014
|
0.78
|
|
38
|
Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
|
Pharmacotherapy
|
2007
|
0.78
|
|
39
|
Sorting out icebergs, mirages, and clinical tuberculosis during active case finding.
|
Am J Respir Crit Care Med
|
2009
|
0.75
|
|
40
|
Short-course regimens for latent tuberculosis: what is ready for prime time?
|
Enferm Infecc Microbiol Clin
|
2007
|
0.75
|
|
41
|
Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients.
|
Clin Infect Dis
|
2005
|
0.75
|